The β‐lactams—a large class of diverse compounds—due to their excellent safety profile
and broad antimicrobial spectrum are considered to be the most widely used therapeutic …

Extended spectrum beta-lactamases (ESBLs) are defined as enzymes produced by certain
bacteria that are able to hydrolyze extended spectrum cephalosporin. They are therefore …

ANTIMICROBIAL RESISTANCE Page 1 2014 ANTIMICROBIAL RESISTANCE Global Report
on Surveillance Page 2 Page 3 2014 ANTIMICROBIAL RESISTANCE Global Report on …

Antibiotic resistance is a problem of deep scientific concern both in hospital and community
settings. Rapid detection in clinical laboratories is essential for the judicious recognition of …

Infections due to Gram-negative bacilli (GNB) are a leading cause of morbidity and mortality
worldwide. The extent of antibiotic resistance in GNB in countries of the Gulf Cooperation …

Background Published data on the existence and magnitude of extended spectrum beta-
lactamase (ESBL) production in urinary pathogens in local setting is limited. The aim of the …

Extended-spectrum β-lactamases producing Escherichia coli (ESBL-EC) lend resistance to
most β-lactam antibiotics. Because of limited treatment options, ESBL-EC infections are …

Antimicrobial resistance (AMR) is a serious public health threat in both developed and
developing countries. Many developing countries, including Rwanda, lack adequate …

The Escherichia coli that produces extended-spectrum lactamases (ESBL-E. coli) can
develop resistance to many antibiotics. The control of ESBL-E. coli disorders is challenging …

Methods: A total of 2209 non-repetitive mid-stream urine (MSU) samples were collected
during the study period (March to September 2014). Identification of the isolates was done …